9. Former name or former address, if changed since last report
N/A
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares
39,677,394,773
Series A Preferred Shares
8,341,500
Series B Preferred Shares
16,658,500
11. Indicate the item numbers reported herein
Item 9 - Other Events
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
ACEN CORPORATIONACEN
PSE Disclosure Form 7-1 - Notice of Annual or Special Stockholders' Meeting References: SRC Rule 17 (SEC Form 17-C) and Sections 7 and 4.4 of the Revised Disclosure Rules
Subject of the Disclosure
Annual Stockholders’ Meeting
Background/Description of the Disclosure
Please be informed that during its regular meeting held on 10 March 2025, the Company's Board of Directors approved the schedule and agenda of the Annual Stockholders’ Meeting of the Company.
Type of Meeting
Annual
Special
Date of Approval by Board of Directors
Mar 10, 2025
Date of Stockholders' Meeting
Apr 23, 2025
Time
9:00 A.M.
Venue
To be conducted virtually via https://conveneagm.com/ph/ACEN2025ASM
Record Date
Mar 28, 2025
Agenda
I. Call to Order II. Certification of Notice and Quorum III. Approval of Minutes of Previous Meeting IV. Ratification of the Acts of the Board of Directors and Officers V. Amendment to the Second Article of the Articles of Incorporation to expand the scope of the Company’s investment business VI. Amendment to the Seventh Article of the Articles of Incorporation to increase the authorized capital stock from Php 48.4 billion to Php 58.4 billion and create additional common shares VII. Election of Directors (including Independent Directors) VIII. Appointment of External Auditor and Fixing of its Remuneration IX. 2024 Audited Financial Statements, including Noting of Annual Report X. Consideration of Such Other Business as May Properly Come Before the Meeting XI. Adjournment
Inclusive Dates of Closing of Stock Transfer Books
Start Date
Mar 29, 2025
End Date
Apr 23, 2025
Other Relevant Information
The deadline for (i) the nomination of directors is March 17, 2025, and (ii) submission of proxies is April 10, 2025.
Filed on behalf by:
Name
Dodjie Lagazo
Designation
General Counsel; Assistant Corporate Secretary; Compliance Officer